loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Ropidoxuridine, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Ropidoxuridine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: 93265-81-7, Ipdr, 5-iodo-2-pyrimidinone-2'-deoxyribose, Ipd-r, 3hx21a3sqf, 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone
    Molecular Formula
    C9H11IN2O4
    Molecular Weight
    338.10  g/mol
    InChI Key
    XIJXHOVKJAXCGJ-XLPZGREQSA-N
    FDA UNII
    3HX21A3SQF
    Ropidoxuridine is an orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine, with radiosensitizing activity. Upon oral administration, ropidoxuridine (IPdR) is efficiently converted to idoxuridine (IUdR) by a hepatic aldehyde oxidase. In turn, IUdR is incorporated into DNA during replication, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. Compared to IUdR, ropidoxuridine is associated with a lower toxicity profile and improved anti-tumor activity.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one
    2.1.2 InChI
    InChI=1S/C9H11IN2O4/c10-5-2-11-9(15)12(3-5)8-1-6(14)7(4-13)16-8/h2-3,6-8,13-14H,1,4H2/t6-,7+,8+/m0/s1
    2.1.3 InChI Key
    XIJXHOVKJAXCGJ-XLPZGREQSA-N
    2.1.4 Canonical SMILES
    C1C(C(OC1N2C=C(C=NC2=O)I)CO)O
    2.1.5 Isomeric SMILES
    C1[C@@H]([C@H](O[C@H]1N2C=C(C=NC2=O)I)CO)O
    2.2 Other Identifiers
    2.2.1 UNII
    3HX21A3SQF
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

    2. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside

    3. 5-iodo-2-pyrimidinone-2'-deoxyribose

    4. Ipdr

    2.3.2 Depositor-Supplied Synonyms

    1. 93265-81-7

    2. Ipdr

    3. 5-iodo-2-pyrimidinone-2'-deoxyribose

    4. Ipd-r

    5. 3hx21a3sqf

    6. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

    7. Nsc-726188

    8. 2(1h)-pyrimidinone, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-iodo-

    9. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one

    10. Ropidoxuridine [usan]

    11. Unii-3hx21a3sqf

    12. Ropidoxuridine (inn/usan)

    13. Ropidoxuridine [usan:inn]

    14. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside

    15. Ropidoxuridine [inn]

    16. Schembl8602575

    17. Chembl2103821

    18. Dtxsid00239353

    19. Zinc6091380

    20. 5-iodo-2-pyrimidinone-2-deoxyribose

    21. Db06485

    22. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one

    23. Hy-13742

    24. Cs-0007768

    25. D08992

    26. D96122

    27. 265i817

    28. A901121

    29. Q27257237

    30. 5-iodo-1-(2-deoxy-beta-d-ribofuranosyl)pyrimidin-2(1h)-one

    31. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodopyrimidin-2(1h)-one

    32. 2(1h)-pyrimidinone, 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodo-

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 338.10 g/mol
    Molecular Formula C9H11IN2O4
    XLogP3-0.5
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count2
    Exact Mass337.97635 g/mol
    Monoisotopic Mass337.97635 g/mol
    Topological Polar Surface Area82.4 Ų
    Heavy Atom Count16
    Formal Charge0
    Complexity357
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in cancer/tumors (unspecified).

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Antineoplastic Agents

    Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

    Post Enquiry
    POST ENQUIRY